Evidence map›Paper›PMID 21949683›Full record

ArticlePloS one2011

The ETS family member TEL binds to nuclear receptors RAR and RXR and represses gene activation.

Magda A Meester-Smoor, Marjolein J F W Janssen, W Martijn ter Haar, Karel H M van Wely, Albert-Jan L H J Aarnoudse, Gertine van Oord, Gabrielle B A van Tilburg, Ellen C Zwarthoff

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Magda A Meester-SmoorDepartment of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands.
Marjolein J F W Janssen
W Martijn ter Haar
Karel H M van Wely
Albert-Jan L H J Aarnoudse
Gertine van Oord
Gabrielle B A van Tilburg
Ellen C Zwarthoff
Meertens Institute · NLErasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinoic acid receptor (RAR) signaling is important for regulating transcriptional activity of genes involved in growth, differentiation, metabolism and reproduction. Defects in RAR signaling have been implicated in cancer. TEL, a member of the ETS family of transcription factors, is a DNA-binding transcriptional repressor. Here, we identify TEL as a transcriptional repressor of RAR signaling by its direct binding to both RAR and its dimerisation partner, the retinoid x receptor (RXR) in a ligand-independent fashion. TEL is found in two isoforms, created by the use of an alternative startcodon at amino acid 43. Although both isoforms bind to RAR and RXR in vitro and in vivo, the shorter form of TEL represses RAR signaling much more efficiently. Binding studies revealed that TEL binds closely to the DNA binding domain of RAR and that both Helix Loop Helix (HLH) and DNA binding domains of TEL are mandatory for interaction. We have shown that repression by TEL does not involve recruitment of histone deacetylases and suggest that polycomb group proteins participate in the process.

Indexed as

Gene Expression RegulationAlternative SplicingBinding, CompetitiveBinding SitesBlotting, WesternCell Line, TumorETS Translocation Variant 6 ProteinHelix-Turn-Helix MotifsHistone Deacetylase InhibitorsHumansHydroxamic AcidsImmunoprecipitationLuciferasesProtein BindingProtein IsoformsProtein MultimerizationETS Translocation Variant 6 ProteinHistone Deacetylase InhibitorsHydroxamic AcidsLuciferasesProtein IsoformsProto-Oncogene Proteins c-etsRARA protein, humanReceptors, Retinoic AcidRepressor ProteinsRetinoic Acid Receptor alphaRetinoid X Receptor alphatrichostatin A

Identifiers

PMID21949683
PMCPMC3174942
OpenAlexW2003032060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.